SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Top Cited Papers
Open Access
Abstract
No abstract available
Funding Information
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung

This publication has 59 references indexed in Scilit: